SG3 Management’s Elevance Health ELV Stock Holding History

SG3 Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$604K	–	383
2019 Q4	$604K	Sell	2,000 -4,500	-69%	-$1.24M	0.04%	133
2019 Q3	$1.56M	Sell	6,500 -500	-7%	-$137K	0.14%	98
2019 Q2	$1.98M	Buy	+7,000	New	+$1.91M	0.22%	92
2019 Q1	–	Sell	-2,500	Closed	-$657K	–	335
2018 Q4	$657K	Sell	2,500 -400	-14%	-$110K	0.17%	98
2018 Q3	$795K	Buy	+2,900	New	+$753K	0.12%	84

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

SG3 Management's ELV Position: Q4 2021 in Review

SG3 Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 2,000 shares — an estimated $746K sold.

SG3 Management first reported a position in ELV in Q2 2019 and held it in 5 quarters. The position peaked at $2.54M in Q2 2019. 1,373 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

SG3 Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
SG3 Management sold 2,000 Elevance Health shares in Q4 2021, an estimated $746K.
SG3 Management first reported a position in Elevance Health in Q2 2019 and held it in 5 quarters.
SG3 Management's Elevance Health position peaked at $2.54M in Q2 2019.
1,373 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.